收藏切换
Review on application research of 225Ac in tumor targeted therapy
收藏切换
PDF
Xin SONG1, 2, 3, Bo-hua XU2, Qiao-yu TAO1, 2, 3, Li-li FU1, 2, 3, Chu-qiao LIU1, 2, 3, Lu-yao SUN1, 2, 3, Yun-liang QIU4, 5
Chinese Journal of New Drugs | 2023, 32(16) : 1644 - 1651
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(16): 1644-1651
Review on application research of 225Ac in tumor targeted therapy
Full
Xin SONG1, 2, 3, Bo-hua XU2, Qiao-yu TAO1, 2, 3, Li-li FU1, 2, 3, Chu-qiao LIU1, 2, 3, Lu-yao SUN1, 2, 3, Yun-liang QIU4, 5
Affiliations
  • 1School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230013, China
  • 2InnoStar Bio-tech Nantong Co., Ltd., Nantong 226133, China
  • 3China Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China
  • 4China State Institute of Pharmaceutical Industry, Shanghai 201203, China
  • 5InnoStar Bio-tech Shanghai Co., Ltd., Shanghai 201203, China
Published: 2023-08-30
Outline
收藏切换

225Ac is one of the most promising radionuclides in alpha particle targeting therapy (targeted alpha therapy, TAT). The alpha particles produced by 225Ac decay have the characteristics of higher linear energy transfer, shorter tissue action distance, less side effects and so on. Therefore, TAT drugs such as small molecules and antibodies labeled with 225Ac have good application prospects in tumor treatment. This paper introduces the decay properties and sources of 225Ac, summarizes the commonly used chelating agents for 225Ac labeling, exemplifies the process of 225Ac labeling, and summarizes the application of 225Ac-labeled compounds in non-clinical and clinical research in the past three years. Finally, the challenges and prospects of 225Ac-labeled TAT drugs are analyzed, which provides a basis for the follow-up development of TAT drugs.

225Ac  /  alpha particles  /  tumor therapy  /  chelating agents  /  non-clinical and clinical studies
Xin SONG, Bo-hua XU, Qiao-yu TAO, Li-li FU, Chu-qiao LIU, Lu-yao SUN, Yun-liang QIU. Review on application research of 225Ac in tumor targeted therapy[J]. Chinese Journal of New Drugs, 2023 , 32 (16) : 1644 -1651 .
Year 2023 volume 32 Issue 16
PDF
35
12
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-08-30
Article Data
Affiliations
History
  • Accepted:2022-08-22
Funding
Affiliations
    1School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230013, China
    2InnoStar Bio-tech Nantong Co., Ltd., Nantong 226133, China
    3China Yangtze Delta Drug Advanced Research Institute, Nantong 226133, China
    4China State Institute of Pharmaceutical Industry, Shanghai 201203, China
    5InnoStar Bio-tech Shanghai Co., Ltd., Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT